Insider Shareholders with Direct Ownership of Janux Therapeutics, Inc. (JANX)
This section provides a comprehensive overview of the insiders with direct ownership of Janux Therapeutics, Inc. (JANX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Janux Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Bregua Corp
> 10% Shareholder |
3,749,250 | 0 | 3,749,250 $213 Million | 1 |
Jun 15, 2021
Added 1.54%
|
|
David Alan Campbell
President and CEO |
0 | 90,000 | 242,054 $13.8 Million | 4 |
Dec 03, 2024
Reduced 5.84%
|
| 10,097 | 0 | 115,139 $6.54 Million | 3 |
Nov 05, 2024
Added 3.85%
|
|
|
Thomas Di Raimondo
Chief Scientific Officer |
0 | 5,000 | 97,938 $5.57 Million | 1 |
Sep 27, 2024
Reduced 0.68%
|
|
Andrew Hollman Meyer
Chief Business Officer |
59,881 | 50,000 | 77,473 $4.4 Million | 3 |
Dec 19, 2024
Added 0.0%
|
| 6,298 | 0 | 70,348 $4 Million | 3 |
Nov 05, 2024
Added 3.17%
|
|
| 7,500 | 0 | 7,500 $426,225 | 1 |
Jul 19, 2024
Added 25.0%
|
|
| 7,500 | 0 | 7,500 $426,225 | 1 |
Jul 19, 2024
Added 25.0%
|
|
| 6,315 | 3,815 | 7,000 $397,810 | 3 |
Sep 13, 2024
Reduced 35.28%
|
|
| 4,212,121 | 2,333,184 | 6,887 $391,388 | 18 |
Sep 30, 2024
Reduced 12.21%
|
|
| 2,500 | 0 | 2,500 $142,075 | 1 |
Jun 26, 2024
Added 50.0%
|
|
| 2,500 | 0 | 2,500 $142,075 | 1 |
Jun 26, 2024
Added 50.0%
|
|
| 2,500 | 0 | 2,500 $142,075 | 1 |
Jun 26, 2024
Added 50.0%
|
|
| 2,500 | 0 | 2,500 $142,075 | 1 |
Jun 26, 2024
Added 50.0%
|